$1.6B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | CGEM Cullinan Therapeutics Inc | 9.7M | +27.2% | $177M | 10.8% |
| 2 | AKTS Aktis Oncology Inc | 4.8M | +0.0% | $156M | 9.5% |
| 3 | LQDA Liquidia Corporation | 1.4M | −1.4% | $111M | 6.7% |
| 4 | RVMD Revolution Medicines Inc | 492,483 | −2.8% | $92M | 5.6% |
| 5 | CORT Corcept Therapeutics Inc | 771,028 | −21.8% | $67M | 4.1% |
| 6 | EWTX Edgewise Therapeutics Inc | 1.6M | −2.4% | $66M | 4.0% |
| 7 | TVTX Travere Therapeutics Inc | 1.1M | −0.9% | $64M | 3.9% |
| 8 | DBVT Dbv Technologies S A | 3.7M | −29.7% | $60M | 3.7% |
| 9 | TRVI Trevi Therapeutics Inc | 3.1M | −6.8% | $57M | 3.5% |
| 10 | ALMS Alumis Inc | 2.0M | −15.4% | $57M | 3.5% |
| 11 | QURE Uniqure Nv | 1.2M | −10.5% | $56M | 3.4% |
| 12 | RARE Ultragenyx Pharmaceutical In | 1.4M | — | $47M | 2.9% |
| 13 | RLAY Relay Therapeutics Inc | 2.4M | +2.4% | $45M | 2.8% |
| 14 | ABVX Abivax Sa | 336,347 | +213.6% | $45M | 2.7% |
| 15 | DYN Dyne Therapeutics Inc | 1.9M | +36.5% | $43M | 2.6% |
| 16 | DNTH Dianthus Therapeutics Inc | 420,002 | −0.9% | $41M | 2.5% |
| 17 | BIOA Bioage Labs Inc | 1.7M | — | $41M | 2.5% |
| 18 | URGN Urogen Pharma Ltd | 933,415 | −1.1% | $34M | 2.1% |
| 19 | MLTX Moonlake Immunotherapeutics | 1.6M | −11.3% | $31M | 1.9% |
| 20 | PVLA Palvella Therapeutics Inc Ne | 204,027 | −1.2% | $31M | 1.9% |
| 21 | TSHA Taysha Gene Therapies Inc | 4.5M | — | $31M | 1.9% |
| 22 | SNDX Syndax Pharmaceuticals Inc | 1.3M | −0.5% | $29M | 1.8% |
| 23 | GLUE Monte Rosa Therapeutics Inc | 1.2M | −1.3% | $28M | 1.7% |
| 24 | ZURA Zura Bio Ltd | 4.5M | — | $26M | 1.6% |
| 25 | NTRA Natera Inc | 92,638 | −0.5% | $25M | 1.5% |
| 26 | STOK Stoke Therapeutics Inc | 723,314 | −5.7% | $24M | 1.4% |
| 27 | ANL Adlai Nortye Ltd | 1.9M | — | $22M | 1.4% |
| 28 | BLTE Belite Bio Inc | 137,208 | +55.8% | $21M | 1.3% |
| 29 | FORTE BIOSCIENCES INC Forte Biosciences Inc | 987,448 | −1.3% | $21M | 1.3% |
| 30 | ORIC Oric Pharmaceuticals Inc | 1.9M | +4.3% | $20M | 1.2% |
| 31 | TARS Tarsus Pharmaceuticals Inc | 322,007 | −2.3% | $20M | 1.2% |
| 32 | ANNX Annexon Inc | 3.5M | — | $20M | 1.2% |
| 33 | DRUG Bright Minds Biosciences Inc | 202,114 | −4.7% | $14M | 0.9% |
| 34 | TRDA Entrada Therapeutics Inc | 1.3M | — | $9M | 0.6% |
| 35 | ACRS Aclaris Therapeutics Inc | 1.0M | +166.0% | $6M | 0.3% |
| 36 | CNTX Context Therapeutics Inc | 1.3M | −87.8% | $719,542 | 0.0% |
| 37 | HOWL Werewolf Therapeutics Inc | 80,142 | −93.4% | $28,851 | 0.0% |